http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15533751

Outgoing Links

Predicate Object
contentType Journal Article
endingPage 77
issn 1179-2728
pageRange 73-77
publicationName Lung Cancer: Targets and Therapy
startingPage 73
bibliographicCitation Deng L, Sharma J, Ravera E, Halmos B, Cheng H. Hypersensitivity in ALK-positive lung cancers exposed to ALK inhibitors: a case of successful switch to an alternative ALK inhibitor and systematic review of the literature. Lung Cancer (Auckl). 2018;9():73–7. PMID: 30233266; PMCID: PMC6134951.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e00246f804721e218f0dff218a21ef14
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_18654c3a4d11216e16f9ced7f14c6e9d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8867-6635
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6e68316fec1f9efc5dfd47b851c59e59
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_544c9d15cf69b884bbcef287e4788f21
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_72565d9eee1a232b22755be8f4185090
date 201809
identifier https://doi.org/10.2147/lctt.s173948
https://pubmed.ncbi.nlm.nih.gov/PMC6134951
https://pubmed.ncbi.nlm.nih.gov/30233266
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/42581
https://portal.issn.org/resource/ISSN/1179-2728
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Hypersensitivity in ALK-positive lung cancers exposed to ALK inhibitors: a case of successful switch to an alternative ALK inhibitor and systematic review of the literature
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68165256
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49806720
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8097
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8096
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8366

Showing number of triples: 1 to 29 of 29.